Summary
18.80 -0.38(-1.98%)09/18/2024
Medifast Inc (MED)
Medifast Inc (MED)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.98 | 2.96 | -3.14 | -4.13 | -47.56 | -76.62 | -79.02 | 351.92 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 18.80 | |
| Open | 19.20 | |
| High | 19.73 | |
| Low | 18.80 | |
| Volume | 130,807 | |
| Change | -0.38 | |
| Change % | -1.98 | |
| Avg Volume (20 Days) | 181,503 | |
| Volume/Avg Volume (20 Days) Ratio | 0.72 | |
| 52 Week Range | 17.74 - 83.60 | |
| Price vs 52 Week High | -77.51% | |
| Price vs 52 Week Low | 5.98% | |
| Range | -2.08 | |
| Gap Up/Down | 0.00 | |
Fundamentals | ||
| Market Capitalization (Mln) | 206 | |
| EBIDTA | 95,525,000 | |
| PE Ratio | 4.0372 | |
| PEG Ratio | 1.9500 | |
| WallStreet Target Price | 25.00 | |
| Book Value | 19.7250 | |
| Earnings Per Share | 6.1900 | |
| EPS Estimate Current Quarter | 0.7800 | |
| EPS Estimate Next Quarter | 0.6700 | |
| EPS Estimate Current Year | 0.7600 | |
| EPS Estimate Next Year | 1.8900 | |
| Diluted EPS (TTM) | 6.1900 | |
| Revenues | ||
| Profit Marging | 0.0755 | |
| Operating Marging (TTM) | 0.0529 | |
| Return on asset (TTM) | 0.1644 | |
| Return on equity (TTM) | 0.3549 | |
| Revenue TTM | 897,809,984 | |
| Revenue per share TTM | 82.4040 | |
| Quarterly Revenue Growth (YOY) | -0.4990 | |
| Quarterly Earnings Growth (YOY) | -0.7930 | |
| Gross Profit (TTM) | 1,140,414,000 | |
| Dividends | ||
| Dividend Share | 3.3000 | |
| Dividend Yield | 0.2641 | |
| Valuations | ||
| Trailing PE | 4.0372 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.7040 | |
| Revenue Enterprise Value | 0.2008 | |
| EBITDA Enterprise Value | 1.5432 | |
| Shares | ||
| Shares Outstanding | 10,937,200 | |
| Shares Float | 9,714,812 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.43 | |
| Insider (%) | 2.69 | |
| Institutions (%) | 91.54 | |
09/18 11:00 EST - accesswire.com
Medifast Inc Is Being Investigated By The Schall Law Firm For Securities Law Violations And Investors Are Invited To Lend A Hand
LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Investigated By The Schall Law Firm For Securities Law Violations And Investors Are Invited To Lend A Hand
LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/17 11:00 EST - accesswire.com
The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/16 11:00 EST - accesswire.com
Investors With Losses In Medifast Inc Are Urged To Help The Schall Law Firm Investigate Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors With Losses In Medifast Inc Are Urged To Help The Schall Law Firm Investigate Possible Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/15 11:00 EST - accesswire.com
Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/14 11:00 EST - accesswire.com
The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake
LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake
LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/13 11:00 EST - accesswire.com
Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/12 11:00 EST - zacks.com
Medifast Trades Near 52-Week Low: Buy, Hold or Sell MED Stock?
Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and capitalize on emerging opportunities.
Medifast Trades Near 52-Week Low: Buy, Hold or Sell MED Stock?
Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and capitalize on emerging opportunities.
09/12 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/11 11:00 EST - accesswire.com
Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/10 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Medifast Inc For Possible Securities Law Violations And Investors With Losses Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Medifast Inc For Possible Securities Law Violations And Investors With Losses Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/09 11:00 EST - accesswire.com
Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry
LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/07 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/06 11:00 EST - accesswire.com
Stakeholders With Losses In Medifast, Inc. Are Urged By The Schall Law Firm To Reach Out About An Inquiry Into Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Stakeholders With Losses In Medifast, Inc. Are Urged By The Schall Law Firm To Reach Out About An Inquiry Into Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/05 11:00 EST - accesswire.com
Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/04 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/03 11:00 EST - accesswire.com
Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/02 11:00 EST - accesswire.com
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Regulations And The Public Is Invited To Join
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Regulations And The Public Is Invited To Join
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
09/01 11:00 EST - accesswire.com
Medifast Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Seeks Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Seeks Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/31 11:00 EST - accesswire.com
An Inquiry By The Schall Law Firm Has Been Launched Into Medifast Inc. For Violating Securities Regulations And Affected Investors Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
An Inquiry By The Schall Law Firm Has Been Launched Into Medifast Inc. For Violating Securities Regulations And Affected Investors Should Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
08/30 11:00 EST - accesswire.com
Medifast Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Urges Individuals With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Medifast Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Urges Individuals With Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.